Literature DB >> 34426481

Initial dosing of intermittent vancomycin in adults: estimation of dosing interval in relation to dose and renal function.

Martin Šíma1, Jan Hartinger2, Tomáš Grus3, Ondřej Slanař2.   

Abstract

OBJECTIVES: Due to the high interindividual variability in vancomycin pharmacokinetics, optimisation of its dosing is still challenging. This study aimed to explore vancomycin pharmacokinetics in adult patients and to propose an easy applicable dosing nomogram for initial treatment.
METHODS: Vancomycin pharmacokinetics was calculated in a two-compartmental model based on therapeutic drug monitoring data. A linear regression model was used to explore the relationship between vancomycin elimination half-life and glomerular filtration rate estimated according the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula.
RESULTS: In the whole study population (n=66), vancomycin volume of distribution, clearance and half-life median (IQR) values were 0.69 (0.58-0.87) L/kg, 0.031 (0.022-0.050) L/h/kg and 14.4 (9.5-25.2) hours, respectively. Vancomycin half-life was associated with glomerular filtration rate (r2=0.4126, p<0.0001) according to the formula: t1/2 (h) = -0.247×eGFRCKD-EPI (mL/min/1.73 m2)+32.89. This relationship was used to construct a dosing nomogram.
CONCLUSIONS: We propose an easy-to-use dosing nomogram for vancomycin therapy initiation that allows individualisation of the dosing interval with respect to the administered dose size and functional renal status. © European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  CKD-EPI; dosing nomogram; glomerular filtration; pharmacokinetics; therapeutic drug monitoring; vancomycin

Mesh:

Substances:

Year:  2019        PMID: 34426481      PMCID: PMC8403779          DOI: 10.1136/ejhpharm-2019-002013

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  13 in total

1.  Vancomycin: a history.

Authors:  Donald P Levine
Journal:  Clin Infect Dis       Date:  2006-01-01       Impact factor: 9.079

2.  A simulation of loading doses for vancomycin continuous infusion regimens in intensive care.

Authors:  Martin Šíma; Karolína Hronová; Jan Hartinger; Ondřej Slanař
Journal:  Infect Dis (Lond)       Date:  2017-05-14

3.  Creatinine Clearance Estimations for Vancomycin Maintenance Dose Adjustments.

Authors:  Martin Šíma; Jan Hartinger; Irena Štenglová Netíková; Ondřej Slanař
Journal:  Am J Ther       Date:  2018 Sep/Oct       Impact factor: 2.688

4.  Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.

Authors:  Pamela A Moise-Broder; Alan Forrest; Mary C Birmingham; Jerome J Schentag
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Development and validation of a novel vancomycin dosing nomogram for achieving high-target trough levels at 2 canadian teaching hospitals.

Authors:  Rosanne Thalakada; Michael Legal; Tim T Y Lau; Tiffany Luey; Josh Batterink; Mary H H Ensom
Journal:  Can J Hosp Pharm       Date:  2012-05

Review 6.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 7.  Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; William A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Pharmacotherapy       Date:  2009-11       Impact factor: 4.705

8.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

9.  Therapeutic drug monitoring of antibiotic agents: evaluation of predictive performance.

Authors:  Martin Šíma; Hana Bakhouche; Jan Hartinger; Tereza Cikánková; Ondřej Slanař
Journal:  Eur J Hosp Pharm       Date:  2017-10-30

Review 10.  Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.

Authors:  Zhi-Kang Ye; Hui-Lin Tang; Suo-Di Zhai
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

View more
  1 in total

1.  Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.

Authors:  Yan-Xia Yu; Jian Lu; Hao-di Lu; Lan Li; Jing-Jing Li; Lu Shi; Lu-Fen Duan; Zhi-Wei Zhuang; Su-Dong Xue; Yi Shen; Lian Tang
Journal:  Eur J Hosp Pharm       Date:  2021-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.